| Corticolimbic fast-tracking: enhanced multimodal integration in functional neurological disorder I Diez, L Ortiz-Terán, B Williams, R Jalilianhasanpour, JP Ospina, ... Journal of Neurology, Neurosurgery & Psychiatry 90 (8), 929-938, 2019 | 101 | 2019 |
| Long-term disability in neuromyelitis optica spectrum disorder with a history of myelitis is associated with age at onset, delay in diagnosis/preventive treatment, MRI lesion … MA Mealy, SE Mossburg, SH Kim, S Messina, N Borisow, ... Multiple sclerosis and related disorders 28, 64-68, 2019 | 79 | 2019 |
| Fearful attachment linked to childhood abuse, alexithymia, and depression in motor functional neurological disorders B Williams, JP Ospina, R Jalilianhasanpour, GL Fricchione, DL Perez The Journal of neuropsychiatry and clinical neurosciences 31 (1), 65-69, 2019 | 73 | 2019 |
| A cross talk between neuronal urokinase-type plasminogen activator (uPA) and astrocytic uPA receptor (uPAR) promotes astrocytic activation and synaptic recovery in the ischemic … A Diaz, P Merino, LG Manrique, JP Ospina, L Cheng, F Wu, V Jeanneret, ... Journal of Neuroscience 37 (43), 10310-10322, 2017 | 70 | 2017 |
| Outpatient physical therapy for functional neurological disorder: a preliminary feasibility and naturalistic outcome study in a US cohort JB Maggio, JP Ospina, J Callahan, AL Hunt, CD Stephen, DL Perez The Journal of Neuropsychiatry and Clinical Neurosciences 32 (1), 85-89, 2020 | 53 | 2020 |
| The effects of positive psychological interventions on medical patients’ anxiety: A meta-analysis L Brown, JP Ospina, CM Celano, JC Huffman Psychosomatic medicine 81 (7), 595-602, 2019 | 45 | 2019 |
| Outcomes from acute attacks of neuromyelitis optica spectrum disorder correlate with severity of attack, age and delay to treatment A Banerjee, J Ng, J Coleman, JP Ospina, M Mealy, M Levy Multiple sclerosis and related disorders 28, 60-63, 2019 | 43 | 2019 |
| Secure attachment and depression predict 6-month outcome in motor functional neurological disorders: a prospective pilot study R Jalilianhasanpour, JP Ospina, B Williams, J Mello, J MacLean, ... Psychosomatics 60 (4), 365-375, 2019 | 40 | 2019 |
| Epidemiology, mechanisms, diagnosis, and treatment of delirium: a narrative review JP Ospina, F King IV, E Madva, CM Celano Clinical Medicine and Therapeutics (CMT), 2018 | 36 | 2018 |
| The role of the anterior and midcingulate cortex in the neurobiology of functional neurologic disorder JP Ospina, R Jalilianhasanpour, DL Perez Handbook of clinical neurology 166, 267-279, 2019 | 31 | 2019 |
| Tissue-type plasminogen activator protects the postsynaptic density in the ischemic brain V Jeanneret, JP Ospina, A Diaz, LG Manrique, P Merino, L Gutierrez, ... Journal of Cerebral Blood Flow & Metabolism 38 (11), 1896-1910, 2018 | 22 | 2018 |
| Individual differences in social network size linked to nucleus accumbens and hippocampal volumes in functional neurological disorder: A pilot study JP Ospina, AG Larson, R Jalilianhasanpour, B Williams, I Diez, A Dhand, ... Journal of affective disorders 258, 50-54, 2019 | 18 | 2019 |
| Functional neuroimaging in patients with catatonia: A systematic review L Duque, M Ghafouri, NA Nunez, JP Ospina, KL Philbrick, JD Port, ... Journal of psychosomatic research 179, 111640, 2024 | 11 | 2024 |
| Ivosidenib for the treatment of IDH1-mutant glioma, grades 2–4: Tolerability, predictors of response, and outcomes TA Lanman, G Youssef, R Huang, R Rahman, M DeSalvo, T Flood, ... Neuro-Oncology Advances 7 (1), vdae227, 2025 | 9 | 2025 |
| Medical and neurologic management of brain tumor patients JP Ospina, PY Wen Current Opinion in Neurology 37 (6), 657-665, 2024 | 2 | 2024 |
| Clinical, molecular and radiological predictors of prognosis in newly diagnosed astrocytoma, IDH-mutant, WHO grade 4 AB Lasica, Z Lan, JJ Miller, A Jiao, I Pan, L Aker, P Prabhakar, J Japo, ... Neuro-Oncology, noaf133, 2025 | 1 | 2025 |
| Prognostic Significance of MGMT Promoter Methylation Status in IDH-mutant Glioma G Youssef, E Aquilanti, JJ Miller, Z Lan, AB Lasica, I Arrillaga-Romany, ... Neuro-Oncology, noaf287, 2025 | | 2025 |
| IMG-21. Prognostic significance of contrast enhancement in newly diagnosed grade 2IDH-mutant glioma V Nakhate, AB Lasica, JJ Miller, J Rousseau, E Aquilanti, ... Neuro-Oncology 27 (Supplement_5), v277-v277, 2025 | | 2025 |
| DISP-30. Impact of distance traveled for clinical trial participation on clinical outcomes in patients with glioblastoma J Rousseau, M Auguste, JP Ospina, V Nakhate, MJ Lim-Fat, G Youssef, ... Neuro-Oncology 27 (Supplement_5), v199-v199, 2025 | | 2025 |
| NCOG-43. Clinical outcomes in patients with molecular vs histological glioblastoma JP Ospina, PS Prabhakar, C Westergaard, A Russ, R Fox, E Wang, J Japo, ... Neuro-Oncology 27 (Supplement_5), v331-v331, 2025 | | 2025 |
